Did your renewal come back with a 1 or a 2 in front of it?

It can. The problem is what it costs to make it safe.

• Self-funding works when you have enough claimants for the average to mean something. 20 employees is roughly 45 covered members.
• One premature birth, transplant or late-stage cancer can exceed the entire year's expected claims by itself.
• Stop-loss caps that, but at 20 lives you need a very low attachment point, and low attachment points are expensive.
• By the time you've bought enough to sleep, your fixed cost approaches fully insured, and you've taken on cash-flow timing and admin duties for the privilege.
• Then there's lasering. A large group absorbs one. A 20-life group can lose 3 good years to it.

Level funding solves the same problem differently. The ceiling is contractual, surplus still comes back, and you still get your claims data. That's why the small-group answer is usually level funded.

Rates published in advance, the way a product on a shelf has a price tag.

• Nobody underwrites you. No census, no medical questions.
• One published rate per coverage tier, from employee only up through family.
• The 24-year-old designer and the 61-year-old welder pay the same. So does a company in rural Montana and one in Manhattan.
• Priced against a large national pool instead of your specific 12 or 40 people.

That's the opposite of ACA small group, where your rate is built from each employee's age and location.

Guaranteed issue means coverage can't be denied for health history. Eligibility conditions still apply and not every employer qualifies.

A stop-loss carrier singles out one person and gives them a much higher deductible than everyone else.

How it plays out:

• Your plan has a $50,000 specific deductible.
• At renewal the carrier sees an employee expected to run $400,000 next year.
• They renew you, but write that one person at $350,000 while everyone else stays at $50,000.
• You're now carrying $350,000 of exposure on someone you thought was covered.

The carrier isn't doing anything improper. They're pricing a known cost instead of a probability.

The problem is asymmetry. A 900-life employer absorbs a laser. A 40-life employer can lose several good years to one. And lasers surface at renewal, when there's little runway to shop.

What to ask for:

• No-new-lasers provision. The carrier can't add a laser at renewal that wasn't already there.
• Rate cap. A contractual ceiling on how much your renewal can rise.
• Together they close both ways a single claimant blows up a small plan.
• Often a low single-digit premium load. Under roughly 200 lives, the cheapest protection in the structure.

If a proposal doesn't state whether lasers are permitted, ask that before you ask about the rate.

Same benefit, new federal name since September 3, 2026.

• CMS and the Small Business Administration adopted CHOICE Arrangement, short for Custom Health Option and Individual Care Expense Arrangement.
• An agency terminology change, not an act of Congress. Bills to write the name into statute have been introduced several times and none has become law.
• The underlying ICHRA regulations still govern, unchanged.
• Nothing about how it works changed. Existing plan documents stay valid. Employers already offering one don't have to do anything.
• Classes, affordability, notice and substantiation are the same rules.

Expect both names for a while. Plan documents, carrier forms and IRS guidance still say ICHRA.

Lower than most people think.

• Level funded: most carriers write at 10 to 25 enrolled employees, some lower in specific states.
• True self-funding with a separate stop-loss placement typically starts around 50.
• Group captives commonly want 50 to 100 before taking a member.
• These are carrier appetite, not statute, so they move. A group declined 2 years ago may be writable today.

Within one metro area, the negotiated price for the same procedure differs by several multiples between facilities.

• Price tracks negotiating leverage, not quality.
• The obvious gain is unit cost.
• The one people miss is downstream. Higher-performing surgeons produce fewer complications, readmissions and revisions. A revision is a second full episode of cost.

The empowering version matters more than the savings version. Most people choosing a surgeon are choosing on a referral and a parking lot. They've never had access to outcome data on physicians in their own network.

Steerage isn't narrowing their choice. It's the first time anyone handed them the information.

It sounds backwards. The employer pays more per prescription and saves money. Three mechanisms.

• Acquisition cost instead of spread. A broad $0 list is almost entirely generics. Traditional contracts price those off a benchmark discount, and the difference between what the plan is billed and what the pharmacy is paid stays in the middle. Acquisition cost plus a transparent dispensing fee removes that layer.
• Abandonment. A significant share of new prescriptions are never picked up, and cost at the counter is a leading reason. At $0, the fill rate goes up.
• Downstream math. A month of a generic statin costs a few dollars. A cardiac admission does not.

Employee pays nothing. Employer pays less. Both sides win on day 1.

Yes. Guaranteed issue shelf-rated plans don't price your group's health.

• One published rate per coverage tier. No age rating, no census collection, no medical questions.
• Eligibility conditions apply and not every employer qualifies.
• For a group that prices badly in the age-rated market, this is frequently the lowest-cost option available.

The trade is design control. Plan designs are fixed, you can't modify them, and you don't get claims data. Against a punitive age-rated renewal, that's usually an acceptable trade.

It's a location question before it's a contribution question. An offer is affordable when the employee's cost for the lowest cost silver plan where they live, minus your monthly contribution, falls at or below a share of household income set each year by the IRS. That share is 10.22% for 2027. Marketplace prices are set by the pricing region the state assigns, so the same dollar contribution can pass in one county and fail in the next. If your people live in several regions, run it by location, not once for the company.

One is contractual. The other is a projection.

• Maximum funding rate: the most you can be billed in the plan year.
• Expected cost: what most groups end up paying once surplus is returned.
• Comparing to a fully insured premium? Use the maximum.
• Comparing a guaranteed premium to someone's projection isn't a comparison, it's a sales technique.

Look at both numbers, and make sure you know which one you're being shown.

No, and this is where most proposals overstate. The design changes share denominators. Steering people to better-rated doctors and auditing what hospitals billed both apply to some of the same claim dollars. Pharmacy contract savings and specialty drug management overlap. Recapturing level-funded margin shrinks the base every other percentage is calculated against.

Add the published ranges naively and you get a number in the low thirties as a share of plan cost. Combined results land meaningfully below that. Any model that sums them is wrong by construction.

No. The savings come from the supply side. The changes here operate on unit price, contract terms and where care is delivered. None require reducing headcount, cutting benefits or changing what an employee is entitled to.

Several make the employee experience better. A $0 copay formulary lowers what they pay at the counter to nothing. A funded HRA can leave an employee with lower out-of-pocket cost on a leaner plan than they had on a richer one.